UMEDIC GROUP BERHAD
KLSE (MYR): UMC (0256)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.625
Today's Change
+0.025 (4.17%)
Day's Change
0.60 - 0.63
Trading Volume
1,379,400
Financial
Market Cap
Market Cap
234 Million
NOSH
374 Million
Latest Quarter
Latest Quarter
31-Jul-2024 [#4]
Announcement Date
04-Sep-2024
Next Quarter
31-Oct-2024
Est. Ann. Date
04-Dec-2024
Est. Ann. Due Date
30-Dec-2024
QoQ | YoY
91.72% | -9.97%
T4Q Result
Revenue | NP to SH
54,570.000 | 8,987.000
RPS | P/RPS
14.59 Cent | 4.28
EPS | P/E | EY
2.40 Cent | 26.00 | 3.85%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.19 | 3.25
QoQ | YoY
-3.6% | -12.88%
NP Margin | ROE
17.03% | 12.49%
F.Y. | Ann. Date
31-Jul-2024 | 04-Sep-2024
Latest Audited Result
Latest Audited Result
31-Jul-2023
Announcement Date
03-Nov-2023
Next Audited Result
31-Jul-2024
Est. Ann. Date
03-Nov-2024
Est. Ann. Due Date
27-Jan-2025
Annual (Unaudited)
Revenue | NP to SH
54,570.000 | 8,987.000
RPS | P/RPS
14.59 Cent | 4.28
EPS | P/E | EY
2.40 Cent | 26.00 | 3.85%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.19 | 3.25
YoY
-12.88%
NP Margin | ROE
17.03% | 12.49%
F.Y. | Ann. Date
31-Jul-2024 | 04-Sep-2024
Annualized Result
Revenue | NP to SH
54,570.000 | 8,987.000
RPS | P/RPS
14.59 Cent | 4.28
EPS | P/E | EY
2.40 Cent | 26.00 | 3.85%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
13.24% | -12.88%
NP Margin | ROE
17.03% | 12.49%
F.Y. | Ann. Date
31-Jul-2024 | 04-Sep-2024
Business Process
| Trailing 4 Quarters | Trailing 8 Quarters | |||
|---|---|---|---|---|
| Available Quarters | 4 Quarters | 8 Quarters | ||
| Continuous Quarters Of Revenue Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
| Continuous Quarters Of Profit Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Continuous Quarters Of Adjusted EPS Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
| Total Dividend Years | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
| Average ROE | 3.28% | 3.81% | ||
| Average Net Profit Margin | 16.88% | 19.77% | ||
| Last 5 Financial Years | Last 10 Financial Years | |||
|---|---|---|---|---|
| Available Years | 5 Years | 10 Years | ||
| Continuous Quarters Of Revenue Growth | 1 / 4 | 25.00% | 1 / 4 | 25.00% |
| Total Positive Profit Years | 4 / 4 | 100.00% | 4 / 4 | 100.00% |
| Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 4 / 4 | 100.00% |
| Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 4 | 0.00% |
| Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 4 | 0.00% |
| Total Dividend Years | 0 / 4 | 0.00% | 0 / 4 | 0.00% |
| Continuous Quarters Of Dividend | 0 / 4 | 0.00% | 0 / 4 | 0.00% |
| Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 4 | 0.00% |
| Continuous Quarters Of Adjusted Dps Growth | 0 / 4 | 0.00% | 0 / 4 | 0.00% |
| Average ROE | 18.34% | 18.34% | ||
| Average Net Profit Margin | 16.86% | 16.86% | ||
Key Result
| T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
|---|---|---|---|---|---|
| Revenue | 54,570 | 54,570 | 54,570 | 46,214 | 46,214 |
| NP to SH | 8,987 | 8,987 | 8,987 | 7,704 | 7,704 |
| Dividend | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 2.40 | 2.40 | 2.40 | 2.06 | 2.06 |
| Adjusted DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
Growth
| LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
|---|---|---|---|---|---|
| Revenue | 27.25% | 23.81% | 20.11% | 9.04% | 19.01% |
| NP to Owner | 91.72% | -9.97% | -12.88% | 35.08% | 25.78% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | 92.86% | -10.00% | -13.04% | 35.00% | 25.58% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
| T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00% | 18.08% | 18.08% | 0.00% | 18.08% | 18.08% | 20.11% | 18.08% | 18.08% |
| NP to Owner | 0.00% | 16.65% | 16.65% | 0.00% | 16.65% | 16.65% | -12.88% | 16.65% | 16.65% |
| Dividend | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Adjusted EPS | 0.00% | 16.50% | 16.50% | 0.00% | 16.50% | 16.50% | -13.04% | 16.50% | 16.50% |
| Adjusted DPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
Discussions
Be the first to like this. Showing 50 of 199 comments
Late QR? hopefully a surprise good result, the ceo is optimistic about the company, but as they have foreign cilents, profits made in FX should increase as MYR is depreciating
2024-03-10 12:14
Share price likely bearish in short term, but prospects still good and transer to main market is progressing well, they are nett cash position and little debt
2024-03-11 14:29
High chance this will RISE from today.
KUALA LUMPUR (March 12): Phillip Capital has maintained its “buy” rating on UMediC Group Bhd at 66 sen with a higher target price (TP) of RM1.08 (from 87 sen) and said UMediC’s 6MFY24 core net profit of RM5.3 million (+7.8% y-o-y) was in line with house forecast but missed consensus estimates.
In a note on Tuesday, the research house said the sequential earnings improvement was mainly driven by better margins from the manufacturing and distribution segments.
“We raise our target price to RM1.08 (from 87 sen) after rolling forward our valuation horizon to FY25, based on unchanged 25x PE multiple.
“We expect the commencement of new factory and product launches to drive stronger earnings delivery ahead.
“Key risks include slowdown in medical equipment demand, and the loss of license,” it said.
2024-03-12 08:52
What happened to this stock...Every week only selling and there is no buying....
2024-03-18 11:03
Collect sikit sikit.. nanti kilang siap, double production..bila transfer main market baru ramai berminat share ni..
2024-03-20 15:20
(UMC) transition to the main market is progressing well on track, according to executive director/chief executive officer Lim Taw Seong.
“We believe that this strategical move is poised to unlock vast new opportunities for us to further growth and expand which underscores our continuous commitment in bringing excellence towards healthcare catering to the evolving needs of the industry,” Lim said in a statement.
“As we continue to expand, we have also started to ramp up our efforts by strengthening our workforce in anticipation of the imminent launch of our new facility slated to commence production in the coming months.
“The new factory will not only double our manufacturing capabilities but also enable us to meet the rising demand for medical consumables globally enabling us to better grow our regional footprint and propel us to new heights,” he added.
2024-03-21 14:25
Added like crazy, no sweat man. So cheap...keep for children or charity . Cheers and all the best to diamond hands holders!
2024-03-29 16:20
Already double check with consultants, its just being cool and not be swayed by nay sayers .. so be rest assured diamond hands holders!
2024-03-29 16:21
Below 0.68 Sauk je..
Most Bumi/Islamic fund beli harga offer pada 0.68, untuk pastikan layak syarat kuota bumiputera untuk transfer ke main board..
Boleh check annual report, sudah ada beberapa Islamic /Bumi fund jadi antara 30 Pemegang saham terbesar syarikat.
2024-04-05 18:58
when the transfer to main market will happen ? i think easily can reach RM1 in weeks
2024-04-23 17:00
I think tomorrow..
On behalf of the Board, Affin Hwang IB wishes to announce that Bursa Securities had, vide its letter dated 18 April 2024, approved the Transfer under the "Health Care" sector.
The Transfer will take effect immediately two (2) market days upon the announcement to Bursa Securities on the transfer date via Bursa Link.
This announcement is dated 18 April 2024.
2024-04-23 17:43
annoucement dated 18th April meaning its thursday....2 market days means friday and monday , so tuesday should have been transferred , but today wednesday meaning 4th day already...maybe need to wait further annoucements.
2024-04-24 10:25
its 2 market days upon annoucement on the transfer date to Bursa...so i think Umedic need to inform the intended transfer date to Bursa first...and after that , 2 days from the date Umedic inform Bursa kot
2024-04-24 12:12
At this valuation, the company needs to prove its able to grow at a double digit CAGR in order to justify it, if they cant the share price will fall off a cliff and they might not deserve such a high valuation
2024-05-14 18:13
UMC might benefit from the tariff impose by USA on China. Buy before it surge !
2024-05-15 14:59
What happened to this stock and HLIB is still recommending to buy and accumulate ...
2024-06-26 10:51
hlib buy = sell. same for focusp, mnhldg. i said umc heading southbound many weeks ago
2024-07-29 16:57
Fwiw, 25 days ago, I published an article showing where I thought was the Accumulation Zone, which was what I had drawn - I thought it could be within 0.62-0.63. So, I queued to buy at 0.63 and today, my trade was executed. Today's low is 0.625. My position size is small, less than 1% capital, as I consider this a C-grade trade. Nevertheless, good to have skin in the game.
Just curious, did anyone else saw my article and took action?
2024-07-29 19:12
I note today's range is reasonably wide - 0.625 to 0.655. Price range like this is likely to fool a lot of day traders, or those watching price ticks whilst market is trading. Many times in my past life, I watched price tickers during the day, and got fooled to change my orders to chase. However, nowadays, I just leave it and don't watch price ticks. More often than not, when we don't chase, when we don't care what the outcome of the trade will be, we get better fills, better trading results, better outcome to the growth of our accounts.
2024-07-29 19:15
For this type of chart, precision matters. I can still be wrong. Price is still downtrending. If it breaks support, then, nothing to do, until price stabilizes. Now, I just follow my plan and queue to sell at what I think will be the Selling Zone and ignore everything else. Plan the trade and trade the plan. Everything else is noise.
2024-07-29 19:16
No rebound yet, any hope for this stock since HLIB is promoting to accumulate this stock to their customers.....
2024-08-07 11:13
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-11-08 16:00:00
ADX
Hourly
BUY
2024-11-08 15:40:00
ADX
5 Mins
SELL
2024-11-08 15:20:00
VOLUME BREAKOUT
5 Mins
BUY
2024-11-08 15:20:00
TURTLE SYSTEM 20
5 Mins
BUY
2024-11-08 15:20:00
TURTLE SYSTEM 55
5 Mins
BUY
Apps
Top Articles
1
Good Articles to Share
Trump win to test limit of presidential power; Harris concedes but vows 'fight'
2
4
BFM Podcast
5
BFM Podcast
6
BFM Podcast
8
BFM Podcast
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Ramesh88
Anytime soon...
2023-09-06 12:13